TNF and rheumatoid arthritis: We have recently described, in a retrospective observational cohort study, that the combination of anti-TNFα with CS appears to be the most “pro-infective” treatment, whereas synthetic immunosuppressant drugs, either alone or associated with CS, were relatively safe in both patients with RA or with SpA (Germano et al., 2014).